Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Merck
McKesson
Moodys
Johnson and Johnson

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 211624

See Plans and Pricing

« Back to Dashboard

NDA 211624 describes FOSAPREPITANT DIMEGLUMINE, which is a drug marketed by Apotex Inc, Baxter Hlthcare Corp, Be Pharms, Fresenius Kabi Usa, Lupin Ltd, Msn Labs Pvt Ltd, Mylan Labs Ltd, Sungen Pharma, and Teva Pharms Usa, and is included in nine NDAs. It is available from ten suppliers. Additional details are available on the FOSAPREPITANT DIMEGLUMINE profile page.

The generic ingredient in FOSAPREPITANT DIMEGLUMINE is fosaprepitant. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fosaprepitant profile page.
Summary for 211624
Tradename:FOSAPREPITANT DIMEGLUMINE
Applicant:Sungen Pharma
Ingredient:fosaprepitant dimeglumine
Patents:0
Suppliers and Packaging for NDA: 211624
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FOSAPREPITANT DIMEGLUMINE fosaprepitant dimeglumine POWDER;INTRAVENOUS 211624 ANDA SunGen Pharma, LLC 70625-300 70625-300-01 1 VIAL, SINGLE-DOSE in 1 CARTON (70625-300-01) > 5 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INTRAVENOUSStrengthEQ 150MG BASE/VIAL
Approval Date:Sep 5, 2019TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKinsey
Harvard Business School
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.